Application no. and date | 11708094.5 (espacenet) (Federated) (European Patent Register), 20110210 | Patent/reg. no. and date | DK/EP 2534153, 20160921 | Publication date | 20121219 | Priority no. and date | US 304277 P, 20100212 | EP pub. no. and date |
EP 2534153 20121219 | Effective date | | Applicant/owner | Pfizer Inc., 235 East 42nd Street
New York, NY 10017, US | Applicant ref. no. | P288186DKEP | Inventor | BASFORD, Patricia, Ann, Pfizer Global Research&Development Ramsgate Road
Sandwich Kent CT13 9NJ, GB, GILLMORE, Adam, Pfizer Global Research&Development Ramsgate road
Sandwich Kent CT13 9NJ, GB, JONES, Matthew, Cameron, Pfizer Global Research&Development Ramsgate Road
Sandwich Kent CT13 9NJ, GB, KOUGOULOS, Eleftherios, 4407 Hopson Road Apartment 2308
Morrisville North Carolina 27560, US, LUTHRA, Suman, Pfizer Global Research&Development Eastern Point Road
Groton Connecticut 06340, US, WALTON, Robert, Pfizer Global Research&Development Ramsgate Road
Sandwich Kent CT13 9NJ, GB, CAMPETA, Anthony, Michael, 12 Deer Lane
Ledyard Connecticut 06339, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/55 (2006.01) , A61K 45/06 (2006.01) , C07C 309/19 (2006.01) , C07C 57/145 (2006.01) , C07D 487/06 (2006.01) | Title | Salte og polymorfer af 8-fluor-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-on | Int. application no. | IB2011050571 | Int. publication no. | WO2011098971 | Related patent (certificate) | CA 2018 00041 | Status | Ændret DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|